Detalhe da pesquisa
1.
Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(2): 230-269, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28188192
2.
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016.
J Natl Compr Canc Netw
; 14(4): 389-400, 2016 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27059188
3.
Structural optimization of non-nucleoside DNA methyltransferase inhibitor as anti-cancer agent.
Bioorg Med Chem Lett
; 26(4): 1272-5, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26774653
4.
Daratumumab proves safe and highly effective in AL amyloidosis.
Br J Haematol
; 185(2): 342-344, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29938774
5.
A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma.
Blood
; 120(14): 2817-25, 2012 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-22833546
6.
An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma.
Blood
; 119(24): 5661-70, 2012 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-22555973
7.
Mature results of MM-011: a phase I/II trial of liposomal doxorubicin, vincristine, dexamethasone, and lenalidomide combination therapy followed by lenalidomide maintenance for relapsed/refractory multiple myeloma.
Am J Hematol
; 89(4): 349-54, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24273135
8.
Therapeutic Targeting of Protein Disulfide Isomerase PDIA1 in Multiple Myeloma.
Cancers (Basel)
; 13(11)2021 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34071205
9.
DNA methylation inhibition in myeloma: Experience from a phase 1b study of low-dose continuous azacitidine in combination with lenalidomide and low-dose dexamethasone in relapsed or refractory multiple myeloma.
Semin Hematol
; 58(1): 45-55, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33509443
10.
Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT).
Blood Cancer J
; 10(5): 53, 2020 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32393732
11.
Expression of RASSF1A, an epigenetically silenced tumor suppressor, overcomes resistance to apoptosis induction by interferons.
Cancer Res
; 66(5): 2785-93, 2006 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16510600
12.
Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
Ann Hematol
; 86(10): 711-7, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17622529
13.
Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis.
PLoS One
; 12(3): e0172996, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28278302
14.
Phase I Study of Anti-GM2 Ganglioside Monoclonal Antibody BIW-8962 as Monotherapy in Patients with Previously Treated Multiple Myeloma.
Oncol Ther
; 4(2): 287-301, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-28261656
15.
Novel Protein Disulfide Isomerase Inhibitor with Anticancer Activity in Multiple Myeloma.
Cancer Res
; 76(11): 3340-50, 2016 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27197150
16.
A synthetic peptide targeting the BH4 domain of Bcl-2 induces apoptosis in multiple myeloma and follicular lymphoma cells alone or in combination with agents targeting the BH3-binding pocket of Bcl-2.
Oncotarget
; 6(29): 27388-402, 2015 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26317541
17.
Direct chromatin PCR (DC-PCR): hypotonic conditions allow differentiation of chromatin states during thermal cycling.
PLoS One
; 7(9): e44690, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22984542
18.
Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
J Clin Oncol
; 24(23): 3771-9, 2006 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-16801630